A brief overview of chikungunya-related pain

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY European journal of pharmacology Pub Date : 2025-05-05 Epub Date: 2025-01-30 DOI:10.1016/j.ejphar.2025.177322
William Antonio Gonçalves , Carla Daiane Ferreira de Sousa , Mauro Martins Teixeira , Daniele G. Souza
{"title":"A brief overview of chikungunya-related pain","authors":"William Antonio Gonçalves ,&nbsp;Carla Daiane Ferreira de Sousa ,&nbsp;Mauro Martins Teixeira ,&nbsp;Daniele G. Souza","doi":"10.1016/j.ejphar.2025.177322","DOIUrl":null,"url":null,"abstract":"<div><div>Pain is an important symptom associated with the arboviral disease caused by the Chikungunya virus (CHIKV). For a significant number of patients, this symptom can persist for months or even years, negatively affecting their quality of life. Unfortunately, pharmacological options for this condition are limited and only partially effective, as the underlying mechanisms associated with CHIKV-induced pain are still poorly understood. The re-emergence of CHIKV has led to new outbreaks, and the expected high prevalence of pain in these global events requires new scientific advances to find more effective solutions. Here we review the main aspects of pain caused by CHIKV infection, such as the anatomy of the affected sites, the prevalence and management of this symptom, the diversity of possible cellular and molecular mechanisms, and finally highlight a promising meningeal pathway to elucidate the mechanisms involved in the unsolved problem of CHIKV-associated pain.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"994 ","pages":"Article 177322"},"PeriodicalIF":4.7000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0014299925000755","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Pain is an important symptom associated with the arboviral disease caused by the Chikungunya virus (CHIKV). For a significant number of patients, this symptom can persist for months or even years, negatively affecting their quality of life. Unfortunately, pharmacological options for this condition are limited and only partially effective, as the underlying mechanisms associated with CHIKV-induced pain are still poorly understood. The re-emergence of CHIKV has led to new outbreaks, and the expected high prevalence of pain in these global events requires new scientific advances to find more effective solutions. Here we review the main aspects of pain caused by CHIKV infection, such as the anatomy of the affected sites, the prevalence and management of this symptom, the diversity of possible cellular and molecular mechanisms, and finally highlight a promising meningeal pathway to elucidate the mechanisms involved in the unsolved problem of CHIKV-associated pain.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基孔肯雅病相关疼痛的简要概述。
疼痛是与基孔肯雅病毒(CHIKV)引起的虫媒病毒性疾病相关的重要症状。对于相当数量的患者来说,这种症状可以持续数月甚至数年,对他们的生活质量产生负面影响。不幸的是,这种情况的药物选择是有限的,而且只有部分有效,因为与chikv引起的疼痛相关的潜在机制仍然知之甚少。CHIKV的再次出现导致了新的疫情,在这些全球事件中预期的高疼痛发生率要求取得新的科学进展,以找到更有效的解决办法。在此,我们回顾了由CHIKV感染引起的疼痛的主要方面,如受感染部位的解剖结构,这种症状的流行和治疗,可能的细胞和分子机制的多样性,并最后强调了一个有希望的脑膜途径来阐明未解决的CHIKV相关疼痛问题所涉及的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
期刊最新文献
Genetic variations in GLP-1R: Impact on diabetes and obesity therapeutics Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in blood Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis 6-Shogaol ameliorates experimental colitis and colitis-associated colorectal cancer in mice through the Nrf2-Keap1 signaling pathway Cinnamaldehyde ameliorates diabetic kidney disease via anti-inflammatory effects: Bridging traditional use and molecular mechanisms
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1